Radioiodinated and astatinated NHC rhodium complexes: Synthesis

Autor: Rajerison, Holisoa, Guérard, François, Mougin-Degraef, Marie, Bourgeois, Mickael, Da Silva, Isidro, Chérel, Michel, Barbet, Jacques, Faivre-Chauvet, Alain, Gestin, Jean-François

Publikováno v: In Nuclear Medicine and Biology May 2014 41 Supplement:e23-e29

Tin Reagents Supported on Liquid Ionic: Design and Applications

Autor: Faye, Djibril, Vybornyi, Mykhailo, Louaisil, Nicolas, Boeda, Fabien, Rajerison, Holisoa, Gestin, Jean-François, Legoupy, Stéphanie

Publikováno v: "titre manquant"
"titre manquant", 2012, Leuven, Belgium. 2012

Date du colloque : 07/2012

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5681c24ccc1ebd112bb3c841928d38ef
https://univ-angers.hal.science/hal-03344496

99mTc/188Re-labeled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution

Autor: Ballot, Sandrine, Noiret, Nicolas, Hindré, François, Denizot, Benoît, Garin, Etienne, Rajerison, Holisoa, Benoit, Jean-Pierre

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Springer Verlag (Germany), 2006, 33, pp.602-607

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b2fafaf0923c71e78cd897008fbf1f59
https://hal.archives-ouvertes.fr/hal-00403503

Contribution of [64Cu]-ATSM PET in molecular imaging of tumour hypoxia compared to classical [18F]-MISO - a selected review.

Autor: Bourgeois, Mickaël, Rajerison, Holisoa, Guerard, François, Mougin-Degraef, Marie, Barbet, Jacques, Michel, Nathalie, Cherel, Michel, Faivre-Chauvet, Alain

Publikováno v: Nuclear Medicine Review; 2011, Vol. 14 Issue 2, p90-95, 6p

Improvement of the Targeting of Radiolabeled and Functionalized Liposomes with a Two-Step System Using a Bispecific Monoclonal Antibody (Anti-CEA × Anti-DTPA-In).

Autor: Rauscher A; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), 6299 CNRS, UMR 892 - INSERM, Université de Nantes , Nantes , France ; Nuclear Medicine Department, Institut de Cancérologie de l'Ouest , Saint Herblain , France., Frindel M; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), 6299 CNRS, UMR 892 - INSERM, Université de Nantes , Nantes , France ; Nuclear Medicine Department, University Hospital Nantes , Nantes , France., Rajerison H; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), 6299 CNRS, UMR 892 - INSERM, Université de Nantes , Nantes , France., Gouard S; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), 6299 CNRS, UMR 892 - INSERM, Université de Nantes , Nantes , France., Maurel C; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), 6299 CNRS, UMR 892 - INSERM, Université de Nantes , Nantes , France., Barbet J; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), 6299 CNRS, UMR 892 - INSERM, Université de Nantes , Nantes , France ; GIP Arronax , Saint Herblain , France., Faivre-Chauvet A; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), 6299 CNRS, UMR 892 - INSERM, Université de Nantes , Nantes , France ; Nuclear Medicine Department, University Hospital Nantes , Nantes , France., Mougin-Degraef M; Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), 6299 CNRS, UMR 892 - INSERM, Université de Nantes , Nantes , France ; Nuclear Medicine Department, University Hospital Nantes , Nantes , France.

Publikováno v: Frontiers in medicine [Front Med (Lausanne)] 2015 Nov 25; Vol. 2, pp. 83. Date of Electronic Publication: 2015 Nov 25 (Print Publication: 2015).